A Real-world Study of Pralsetinib Combined With Leucogen in the Treatment of RET Fusion-positive NSCLC
Clinical trial NCT07418879 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07418879
- Sponsor
- Fudan University
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-05
- Primary completion
- 2027-12-31
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.